Chatbot Localization for Life Sciences

Respond to queries faster, more accurately, in any language, and with specialized and customized informative responses.

Get in Touch
Person holding up a chatbot icon

Engage your key stakeholders with conversational AI

Life sciences organizations are increasingly looking for ways to better leverage data to improve the consumer experience. With the majority of the global population conducting research online about products and services they are interested in, now more than ever, chatbots represent a unique opportunity to effectively engage key stakeholder requests with informative and fast responses.

TransPerfect Life Sciences has the experience and expertise to help you reach key stakeholders around the world through language AI support for training conversational AI technology. Our services include generating datasets, annotating unstructured language data to train conversational technology, and, of course, chatbot localization.

Thank

Respond to patient and HCP multilingual queries faster without sacrificing quality

Our expert linguists are experienced in localizing life sciences chatbots to better reach and engage patients, HCPs, and other stakeholders globally in more than 200 languages.

Chatbot Localization for Catalia Health

Simplify Multilingual Conversational AI

Whether it’s creating a virtual agent to help train employees, enhancing an existing virtual agent to answer consumer queries, or localizing a chatbot to engage a new audience, TransPerfect’s AI division, DataForce, can support your development of specialized chatbots trained in clinical and medical terminology that can easily integrate with your systems. We have a simple recipe for success:

  • Icon Signed

Design:

Prototypes and designs are created and tested, and feedback is collected to implement changes.

  • Icon AI Integrations

Build:

Conversational AI models are developed and integrated with existing systems before defining business logic, including prompt localization.

  • Icon Computer with Charts

Manage:

Chatbots are deployed, modified, and tested across all voice and chat channels to ensure optimal user experience.

  • Icon Lightbulb

Enhance:

Once deployed, quality analysis is conducted to improve accuracy and engagement with automated testing.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Let’s Chat About Your Chatbot Localization Strategy.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for medical affairs teams in reaching global audiences.

AI and Medical Device Regulations: Why Human Experts Still Sign Off

In our previous post, we covered the EUDAMED deadline for SSCPs and SSPs, which came up again and again at the RAPS Convergence Conference in Charlotte, North Carolina. In this post, we’re diving into another theme that was just as hard to miss: what AI means for the people who do regulatory work. That was the subject of an overflow session titled “How Is AI Affecting the Regulatory Workforce?” The question behind most of the discussion: Will AI take our jobs? The ...

AI and Medical Device Regulations: Why Human Experts Still Sign Off

How to Select the Right Regulatory Writing Company for Your Organization's Needs

In a landscape defined by ever-evolving global guidelines from health authorities, many life sciences organizations’ clinical and regulatory teams face challenges in navigating the regulatory affairs writing and document submission process. Adhering to strict rules while...

LifeSci Talks COA Series | Clinical Trial Site Burden: Why One Study Can Mean Up to 15 Systems

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of Clinical Technologies at Almac Clinical Technologies, to talk about the burden clinical trial sites face when one study runs on up to ...

Governing AI for Global Content in the Life Sciences Industry

AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and ...

MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

As soon as possible, but no later than March 27, 2027 (per MDCG 2026-4), medical device manufacturers must upload their validated, translated Summaries of Safety and Clinical Performance (SSCPs) to EUDAMED themselves. IVD manufacturers have the same responsibility for their...

Reddit Stories: AI Failures in Clinical Trials

Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...

Are Legacy COA Instruments Still Fit for Purpose?

The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....